- Report
- July 2024
- 120 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- June 2025
- 168 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- May 2025
- 186 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- January 2022
- 115 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- April 2023
- 119 Pages
Global
From €4031EUR$4,500USD£3,436GBP
- Report
- November 2021
- 270 Pages
Global
From €2239EUR$2,500USD£1,909GBP
The Peptide Microarray market is a subset of the biotechnology industry that focuses on the development and production of peptide microarrays. These microarrays are used to detect and measure the presence of peptides in a sample, and are used in a variety of research and clinical applications. Peptide microarrays are used to identify biomarkers, measure drug efficacy, and study protein-protein interactions. They are also used to study the effects of post-translational modifications on protein function.
The Peptide Microarray market is highly competitive, with a number of companies offering products and services. Companies in the market include Agilent Technologies, Bio-Rad Laboratories, Merck Millipore, PerkinElmer, and Thermo Fisher Scientific. Show Less Read more
